MA43488B1 - Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis - Google Patents

Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis

Info

Publication number
MA43488B1
MA43488B1 MA43488A MA43488A MA43488B1 MA 43488 B1 MA43488 B1 MA 43488B1 MA 43488 A MA43488 A MA 43488A MA 43488 A MA43488 A MA 43488A MA 43488 B1 MA43488 B1 MA 43488B1
Authority
MA
Morocco
Prior art keywords
psoriasis
prevention
treatment
probiotics
lactis
Prior art date
Application number
MA43488A
Other languages
English (en)
Other versions
MA43488A1 (fr
Inventor
Lopez Vicente Manuel Navarro
Bosca Ana Adela Ramirez
Orquin José Manuel Perez
Vidal Daniel Ramon
Martinez Salvador Genoves
Cuadros Maria Empar Chenoll
Cortes Francisco Manuel Codoner
Original Assignee
Bionou Res S L
Korott S L
Biopolis SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionou Res S L, Korott S L, Biopolis SL filed Critical Bionou Res S L
Publication of MA43488A1 publication Critical patent/MA43488A1/fr
Publication of MA43488B1 publication Critical patent/MA43488B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne l'utilisation d'une composition probiotique comprenant bifidobacterium animalissous-esp., lactis (b. Lactis), bifidobacterium longum er lactobacillus rhamnosus, en particulier les souches b. Lactis cect 8145, b. Longumes1 cect 7347 et/ou l. Rhamnosus cect 8361, dans le traitement et/ou la prévention de poussées de psoriasis ou du psoriasis.
MA43488A 2016-03-21 2017-03-21 Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis MA43488B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382122.6A EP3222282A1 (fr) 2016-03-21 2016-03-21 Utilisation de probiotiques dans le traitement et/ou la prévention du psoriasis
PCT/EP2017/056719 WO2017162683A1 (fr) 2016-03-21 2017-03-21 Utilisation de probiotiques dans le traitement et/ou la prévention du psoriasis

Publications (2)

Publication Number Publication Date
MA43488A1 MA43488A1 (fr) 2019-12-31
MA43488B1 true MA43488B1 (fr) 2020-10-28

Family

ID=55969084

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43488A MA43488B1 (fr) 2016-03-21 2017-03-21 Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis

Country Status (25)

Country Link
US (1) US10912802B2 (fr)
EP (2) EP3222282A1 (fr)
KR (1) KR102303587B1 (fr)
CN (1) CN110325198B (fr)
AR (1) AR107921A1 (fr)
AU (1) AU2017238300B2 (fr)
CA (1) CA3018625A1 (fr)
DK (1) DK3432899T3 (fr)
EA (1) EA201891908A1 (fr)
ES (1) ES2873889T3 (fr)
HR (1) HRP20211173T1 (fr)
HU (1) HUE055635T2 (fr)
IL (1) IL261932B2 (fr)
MA (1) MA43488B1 (fr)
MX (1) MX2018011593A (fr)
MY (1) MY193275A (fr)
PE (1) PE20190432A1 (fr)
PH (1) PH12018502042A1 (fr)
PL (1) PL3432899T3 (fr)
PT (1) PT3432899T (fr)
RS (1) RS62101B1 (fr)
RU (1) RU2767967C2 (fr)
SI (1) SI3432899T1 (fr)
UA (1) UA127180C2 (fr)
WO (1) WO2017162683A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002052A1 (it) 2018-01-26 2019-07-26 Girolamo Stefano Di Probiotico per il trattamento della psoriasi
EP3851115A1 (fr) * 2020-01-15 2021-07-21 Biopolis, S.L. Composition probiotique pour son utilisation en tant qu'antioxydant
US20210275612A1 (en) * 2020-03-09 2021-09-09 Glac Biotech Co., Ltd. Method for alleviating inflammation-related disorder
CN113142554A (zh) * 2020-06-09 2021-07-23 江苏佰澳达生物科技有限公司 一种改善头皮屑产生的益生菌发酵液及其应用
EP3967318A1 (fr) * 2020-09-14 2022-03-16 Bionou Research, S.L. Compositions probiotiques pour le traitement de l'acné
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
WO2022090474A1 (fr) * 2020-10-29 2022-05-05 Deerland Probiotics & Enzymes A/S Composition microbienne micro-encapsulée
CN112546074B (zh) * 2020-12-24 2022-09-27 江南大学 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用
CN112812989B (zh) * 2020-12-31 2022-06-10 江南大学 一种能够缓解银屑病的青春双歧杆菌及其应用
CN113088473B (zh) * 2021-04-27 2022-08-02 江南大学 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌
CN113455549B (zh) * 2021-06-29 2022-09-13 黑龙江飞鹤乳业有限公司 一种奶酪产品及其制备方法和应用
EP4429686A1 (fr) * 2021-12-16 2024-09-18 Biopolis, S.L. Utilisation de postbiotiques dans le traitement et/ou la prévention de troubles de l'anxiété

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005525348A (ja) * 2002-02-21 2005-08-25 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚のための光防護性の経口投与可能な組成物
JP2004250337A (ja) 2003-02-18 2004-09-09 Sunstar Inc アレルギー疾患改善用製剤
CN101384269B (zh) * 2005-10-06 2012-11-14 普罗比公司 乳酸杆菌用于治疗病毒感染的用途
US8420376B2 (en) * 2005-10-06 2013-04-16 Probi Ab Use of Lactobacillus for treatment of virus infections
ES2343499B1 (es) * 2007-12-24 2011-06-10 Consejo Superior De Investigaciones Cientificas Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
ES2702490T3 (es) * 2011-05-03 2019-03-01 Dupont Nutrition Biosci Aps Bacterias probióticas para el tratamiento tópico de trastornos de la piel
KR20130049554A (ko) 2011-11-04 2013-05-14 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
KR101453982B1 (ko) * 2012-09-19 2014-10-28 주식회사 쎌바이오텍 과민성 대장 증후군 예방 또는 치료용 조성물
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
KR101724601B1 (ko) 2014-11-04 2017-04-10 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
TWI829098B (zh) * 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物

Also Published As

Publication number Publication date
US10912802B2 (en) 2021-02-09
KR102303587B1 (ko) 2021-09-17
PE20190432A1 (es) 2019-03-21
RS62101B1 (sr) 2021-08-31
HUE055635T2 (hu) 2021-12-28
BR112018069284A2 (pt) 2019-03-06
AU2017238300A1 (en) 2018-11-01
PH12018502042A1 (en) 2019-07-15
MA43488A1 (fr) 2019-12-31
CN110325198A (zh) 2019-10-11
EP3432899A1 (fr) 2019-01-30
EP3222282A1 (fr) 2017-09-27
UA127180C2 (uk) 2023-05-31
MY193275A (en) 2022-09-29
RU2767967C2 (ru) 2022-03-23
HRP20211173T1 (hr) 2021-10-15
AU2017238300B2 (en) 2024-07-11
MX2018011593A (es) 2020-01-30
RU2018136939A3 (fr) 2020-05-13
KR20190008849A (ko) 2019-01-25
EP3432899B1 (fr) 2021-04-28
ES2873889T3 (es) 2021-11-04
IL261932A (en) 2018-10-31
IL261932B (en) 2022-12-01
EA201891908A1 (ru) 2019-04-30
DK3432899T3 (da) 2021-07-05
US20190328799A1 (en) 2019-10-31
RU2018136939A (ru) 2020-04-22
CN110325198B (zh) 2024-04-30
IL261932B2 (en) 2023-04-01
AR107921A1 (es) 2018-06-28
CA3018625A1 (fr) 2017-09-28
SI3432899T1 (sl) 2021-12-31
PT3432899T (pt) 2021-07-05
PL3432899T3 (pl) 2021-11-22
WO2017162683A1 (fr) 2017-09-28

Similar Documents

Publication Publication Date Title
MA43488B1 (fr) Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis
MA44893A1 (fr) Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique
NZ737752A (en) Compositions comprising bacterial strains
WO2018013583A3 (fr) Cocktail de lactobacillus vaginal médicinal
WO2016086209A8 (fr) Compositions probiotiques et prébiotiques et procédés pour les utiliser pour le traitement de troubles gastro-intestinaux
MX2008006546A (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
IT201600091033A1 (it) Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
SA113340703B1 (ar) سلالة جديدة من بكتيريا Lactobacillus Crispatus
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
DK3554517T3 (da) Probiotisk sammensætning omfattende lactobacillus rhamnosus og lactobacillus paracasei stammer
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina
PH12017502042A1 (en) Dietary supplement
EP3601525C0 (fr) Souche de lactobacillus casei probiotique et ses utilisations
EA202191106A1 (ru) Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus
MX2024006254A (es) Uso de postbioticos en el tratamiento y/o prevencion de los trastornos de ansiedad.
UA120331U (uk) Пробіотик "болмол"
MX2020007906A (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.
Tehrani et al. The effect of some lactobacillus species (probiotics) on biofilm inhibition in Enterococcus faecium
RS54225B1 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
RU2012102853A (ru) Штамм lactococcus casei вкпм в-8730, используемый для приготовления кисло-молочных продуктов и пробиотических препаратов
UA93301U (uk) Композиційний біопрепарат для лікування запалення тканин пародонту і корекції асоційованих гастродуоденальних розладів кишечнику у дітей